Compounds > clonazepam

clonazepam and warfarin

clonazepam has been researched along with warfarin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	1 (9.09)	18.2507
2000's	4 (36.36)	29.6817
2010's	4 (36.36)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Jolivette, LJ; Ward, KW	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P	1
Bertucci, C; Carocci, A; Carrieri, A; Catalano, A; Conte Camerino, D; Corbo, F; De Bellis, M; De Luca, A; Desaphy, JF; Fortugno, C; Franchini, C; Muraglia, M	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fitos, I; Kajtár, J; Magyar, A; Simonyi, M; Visy, J	1
Fitos, I; Simonyi, M	1
Corbel, T; de Gunzburg, J; Ducher, A; Féger, C; Gaumétou, O; Mentré, F; Meyers, D; Pinquier, JL; Sayah-Jeanne, S; Varastet, M	1

Reviews

1 review(s) available for clonazepam and warfarin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for clonazepam and warfarin

Article	Year
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects. Clinical pharmacology in drug development, 2021, Volume: 10, Issue:8 Topics: Adult; Area Under Curve; Charcoal; Clonazepam; Cross-Over Studies; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Therapeutic Equivalency; Warfarin; Young Adult	2021

Other Studies

9 other study(ies) available for clonazepam and warfarin

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions. Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21 Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence	2010
N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels. Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Chromatography, Affinity; Chromatography, High Pressure Liquid; Humans; Models, Molecular; Muscle, Skeletal; Patch-Clamp Techniques; Protein Binding; Quantitative Structure-Activity Relationship; Rats; Serum Albumin; Sodium Channels; Structure-Activity Relationship; Tocainide; Voltage-Gated Sodium Channel Blockers	2014
Stereoselective effect of warfarin and bilirubin on the binding of 5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2- one enantiomers to human serum albumin. Chirality, 1990, Volume: 2, Issue:3 Topics: Anti-Anxiety Agents; Benzodiazepines; Bilirubin; Chromatography, Affinity; Circular Dichroism; Clonazepam; Humans; Pharmacology; Serum Albumin; Stereoisomerism; Warfarin	1990
Selective effect of clonazepam and (S)-uxepam on the binding of warfarin enantiomers to human serum albumin. Journal of chromatography, 1988, Oct-21, Volume: 450, Issue:2 Topics: Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Clonazepam; Humans; Protein Binding; Serum Albumin; Stereoisomerism; Warfarin	1988